English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
龍德健康產業園成功封頂 金活醫藥打造龍崗醫藥新名片
Oct 07, 2022 21:39 HKT
Novotech 当选 Scrip 奖最佳入围者 全方位服务的临床研究机构
Oct 07, 2022 15:00 HKT
Novotech 當選 Scrip 獎最佳入圍者 全方位服務的臨床研究機構
Oct 07, 2022 15:00 HKT
Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO
Oct 07, 2022 10:00 HKT
中国疫苗行业的主要参与者艾美疫苗于香港联合交易所主板挂牌
Oct 06, 2022 19:18 HKT
中國疫苗行業的主要參與者艾美疫苗於香港聯合交易所主板掛牌
Oct 06, 2022 19:17 HKT
AIM Vaccine, a Major Player in the Chinese Vaccine Industry, Successfully Listed on the Main Board of SEHK
Oct 06, 2022 19:16 HKT
艾美疫苗公布全球发售结果 每股H股发售股份发售价为16.16港元
Oct 05, 2022 18:57 HKT
艾美疫苗公佈全球發售結果 每股H股發售股份發售價為16.16港元
Oct 05, 2022 18:56 HKT
AIM Vaccine Announces Global Offering Results, Offer Price of HK$16.16 per H Share
Oct 05, 2022 18:55 HKT
多宁生物拟赴港上市:先发优势显著 业绩增长强劲
Oct 05, 2022 18:46 HKT
多寧生物擬赴港上市:先發優勢顯著 業績增長強勁
Oct 05, 2022 18:45 HKT
臻和科技递表港交所:NGS技术领衔业界 财务优势可圈可点
Oct 05, 2022 10:12 HKT
臻和科技遞表港交所:NGS技術領銜業界 財務優勢可圈可點
Oct 05, 2022 10:11 HKT
Bio Farma secures Multi-year Purchase Contract from UNICEF for its novel Oral Polio Vaccine type 2 (nOPV2)
Oct 04, 2022 07:00 HKT
Bio Farma to Export its Polio Vaccine After Securing Purchase Contracts from UNICEF for 2022 and 2023
Sep 30, 2022 18:00 HKT
Q&M Group awards 7 Dentists with Performance Shares, 12-year Service Agreements, and a Private Placement
Sep 30, 2022 15:00 HKT
아방스 클리니컬, 바이오테크 CRO 서비스 국제 보건상 수상
Sep 29, 2022 22:00 HKT
乐普生物PD-1单抗普佑恒(TM)获批新适应症,MRG003获CDE纳入突破性治疗药物名单
Sep 29, 2022 15:42 HKT
樂普生物PD-1單抗普佑恒(TM)獲批新適應症,MRG003獲CDE納入突破性治療藥物名單
Sep 29, 2022 15:41 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: